These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 24431397

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
    Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Ramming A, Krasowska D, Michalska-Jakubus M, Kreuter A, Kraner ME, Schett G, Distler JHW.
    Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
    [Abstract] [Full Text] [Related]

  • 23. The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis.
    Zehender A, Huang J, Györfi AH, Matei AE, Trinh-Minh T, Xu X, Li YN, Chen CW, Lin J, Dees C, Beyer C, Gelse K, Zhang ZY, Bergmann C, Ramming A, Birchmeier W, Distler O, Schett G, Distler JHW.
    Nat Commun; 2018 Aug 14; 9(1):3259. PubMed ID: 30108215
    [Abstract] [Full Text] [Related]

  • 24. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O.
    Arthritis Rheum; 2007 Jan 14; 56(1):311-22. PubMed ID: 17195235
    [Abstract] [Full Text] [Related]

  • 25. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J.
    Arthritis Rheum; 2004 Dec 14; 50(12):4008-21. PubMed ID: 15593186
    [Abstract] [Full Text] [Related]

  • 26. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J, Beyer C, Palumbo-Zerr K, Zhang Y, Ramming A, Distler A, Gelse K, Distler O, Schett G, Wollin L, Distler JH.
    Ann Rheum Dis; 2016 May 14; 75(5):883-90. PubMed ID: 25858641
    [Abstract] [Full Text] [Related]

  • 27. JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment.
    Zhang Y, Liang R, Chen CW, Mallano T, Dees C, Distler A, Reich A, Bergmann C, Ramming A, Gelse K, Mielenz D, Distler O, Schett G, Distler JHW.
    Ann Rheum Dis; 2017 Aug 14; 76(8):1467-1475. PubMed ID: 28478401
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis.
    Horn A, Kireva T, Palumbo-Zerr K, Dees C, Tomcik M, Cordazzo C, Zerr P, Akhmetshina A, Ruat M, Distler O, Beyer C, Schett G, Distler JH.
    Ann Rheum Dis; 2012 May 14; 71(5):785-9. PubMed ID: 22402139
    [Abstract] [Full Text] [Related]

  • 30. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, Palumbo K, Zwerina J, Nevskaya T, Gay S, Distler O, Schett G, Distler JH.
    Arthritis Rheum; 2010 Jan 14; 62(1):280-90. PubMed ID: 20039427
    [Abstract] [Full Text] [Related]

  • 31. PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis.
    Zhang Y, Shen L, Zhu H, Dreissigacker K, Distler D, Zhou X, Györfi AH, Bergmann C, Meng X, Dees C, Trinh-Minh T, Ludolph I, Horch R, Ramming A, Schett G, Distler JHW.
    Ann Rheum Dis; 2020 Sep 14; 79(9):1227-1233. PubMed ID: 32482644
    [Abstract] [Full Text] [Related]

  • 32. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C, Uehara A, Sekiguchi A, Uchiyama A, Yamazaki S, Ogino S, Yokoyama Y, Torii R, Hosoi M, Suto C, Tsunekawa K, Murakami M, Ishikawa O, Motegi SI.
    Arthritis Rheumatol; 2019 Feb 14; 71(2):302-314. PubMed ID: 30175895
    [Abstract] [Full Text] [Related]

  • 33. The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis.
    Krönke G, Reich N, Scholtysek C, Akhmetshina A, Uderhardt S, Zerr P, Palumbo K, Lang V, Dees C, Distler O, Schett G, Distler JH.
    Ann Rheum Dis; 2012 Jun 14; 71(6):1081-7. PubMed ID: 22267335
    [Abstract] [Full Text] [Related]

  • 34. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
    Wei J, Ghosh AK, Chu H, Fang F, Hinchcliff ME, Wang J, Marangoni RG, Varga J.
    Arthritis Rheumatol; 2015 May 14; 67(5):1323-34. PubMed ID: 25707573
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan 14; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 36. The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis.
    Palumbo K, Zerr P, Tomcik M, Vollath S, Dees C, Akhmetshina A, Avouac J, Yaniv M, Distler O, Schett G, Distler JH.
    Ann Rheum Dis; 2011 Jul 14; 70(7):1320-6. PubMed ID: 21515915
    [Abstract] [Full Text] [Related]

  • 37. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
    Dees C, Tomcik M, Zerr P, Akhmetshina A, Horn A, Palumbo K, Beyer C, Zwerina J, Distler O, Schett G, Distler JH.
    Ann Rheum Dis; 2011 Jul 14; 70(7):1304-10. PubMed ID: 21450749
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
    Chen CW, Beyer C, Liu J, Maier C, Li C, Trinh-Minh T, Xu X, Cole SH, Hsieh MH, Ng N, Althage A, Meeusen S, Pan S, Svensson EC, Seidel HM, Schett G, Gergely P, Harris JL, Distler JH.
    Ann Rheum Dis; 2017 Apr 14; 76(4):773-778. PubMed ID: 28153829
    [Abstract] [Full Text] [Related]

  • 39. The JAK2 pathway is activated in idiopathic pulmonary fibrosis.
    Milara J, Hernandez G, Ballester B, Morell A, Roger I, Montero P, Escrivá J, Lloris JM, Molina-Molina M, Morcillo E, Cortijo J.
    Respir Res; 2018 Feb 06; 19(1):24. PubMed ID: 29409529
    [Abstract] [Full Text] [Related]

  • 40. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S.
    Arthritis Rheum; 2010 Aug 06; 62(8):2476-87. PubMed ID: 20506342
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.